Kefpod o Final Pres
Transcript of Kefpod o Final Pres
-
8/13/2019 Kefpod o Final Pres
1/43
-
8/13/2019 Kefpod o Final Pres
2/43
Gastrointestinal tract
-
8/13/2019 Kefpod o Final Pres
3/43
Digestive System
Functions:
It is involved in
Ingestion
Digestion
Absorption
Excretion of the food
-
8/13/2019 Kefpod o Final Pres
4/43
Common worldwide bacterial
disease
An acute illness associated with
fever that is most often caused
by the Salmonella typhibacteria
Transmitted by the ingestion of
contaminated food or water
-
8/13/2019 Kefpod o Final Pres
5/43
Typhoid
Typhoid (Enteric fever) remains endemic in many areas of the
developing world
Causes over 26 million infections and over 2,00,000 deaths annually
Incidence is highest in south-central Asia and South East Asia (over
100/100 000 cases/year), with the highest burden of disease in
children aged 2-15 years
Thaver D. BMJ 2009;338:b1865
http://localhost/var/www/apps/conversion/tmp/scratch_7//upload.wikimedia.org/wikipedia/commons/5/58/Fievre_typhoide.png -
8/13/2019 Kefpod o Final Pres
6/43
Typhoid
Causes:
Caused by several species of Salmonella: S. typhi, S.
paratyphi
The proximate cause in most cases is water or food
contamination by a human carrier
-
8/13/2019 Kefpod o Final Pres
7/43
Typhoid
Symptoms Incubation period - 1 to 2 wks
Duration of the illness - 4 to 6 wks
The patient experiences poor appetite
abdominal pain
headaches
generalized aches and pains;
fever, often up to 104 F;
lethargy (usually only if untreated);
-
8/13/2019 Kefpod o Final Pres
8/43
Some people with typhoid fever develop a rash called "rose
spots," which are small red spots on the abdomen and
chest.
Typhoid
Symptoms
http://localhost/var/www/apps/conversion/tmp/scratch_7//upload.wikimedia.org/wikipedia/commons/1/12/Salmonella_typhi_typhoid_fever_PHIL_2215_lores.jpg -
8/13/2019 Kefpod o Final Pres
9/43
Diagnosis
A complete blood count (CBC) will show a high number of white blood cells.
A blood culture during the first week of the fever can show S. typhibacteria.
Widal test : "O" agglutinin antibody titer 1:80 and "H" 1:160 or "O" 4
times higher supports a diagnosis of typhoid fever
Other tests that can help diagnose this condition include:
ELISA urine test to look for the bacteria that cause Typhoid fever
Fluorescent antibody study to look for substances that are specific to Typhoid
bacteria
Platelet count (platelet count will be low)
Stool culture
-
8/13/2019 Kefpod o Final Pres
10/43
Complication
Intestinal hemorrhage
Intestinal perforation
Encephalitis
Metastatic abscesses
Cholecystitis
Endocarditis
-
8/13/2019 Kefpod o Final Pres
11/43
Antibiotics and supportive care (IV fluids)
Prior to the use of antibiotics, the fatality rate was 20%
With antibiotics and supportive care, mortality has
been reduced to 1%-2%
With appropriate antibiotic therapy, there is usually
improvement within 1-2 days and recovery within 7-10
days
-
8/13/2019 Kefpod o Final Pres
12/43
Antibiotics are the mainstay of the
therapy in the management of Typhoid
-
8/13/2019 Kefpod o Final Pres
13/43
Chloramphenicol
Ampicillin
Trimethoprim-sulfamethoxazole
Fluroquinolones like ciprofloxacin, ofloxacin
Third generation cephalosporins like ceftriaxone
(injectable)
-
8/13/2019 Kefpod o Final Pres
14/43
Treatment
Chloramphenicol was the original drug of choice for manyyears.
Advantages:
Low cost, wide availability
Disadvantage:
Not reduces the relapse rate
No effect on carrier state
Not useful for treating MDR s typhi.
Rare serious side effects
-
8/13/2019 Kefpod o Final Pres
15/43
Fluoroquinolones (ciprofloxacin, ofloxacin, enoxacin,
and pefloxacin) are a large family of anti-infective drugs
synthesized around the quinolone core and that
possess a broad antibacterial spectrum (Congeni 2002).
Fluoroquinolones effectively penetrate macrophages
and achieve high concentrations in bile (Miller 2000).
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) (Review) 10 Copyright 2008 TheCochrane Collaboration. Published by JohnWiley & Sons, Ltd.
-
8/13/2019 Kefpod o Final Pres
16/43
-
8/13/2019 Kefpod o Final Pres
17/43
Antibiotics like fluroquinolones and thirdgeneration cephalosporins the mainstay
of the therapy in the management of
Typhoid
-
8/13/2019 Kefpod o Final Pres
18/43
MDR strains of S. Typhi, carrying resistance to all
conventional first-line antibiotics (chloramphenicol, co-
trimoxazole, and ampicillin or amoxicillin), have become
highly prevalent in several areas of the world since 1989
In the Indian subcontinent and China, the frequency of
these MDR strains ranged from 50% to 80% of all S. Typhiisolates and reached 100% during outbreaks (Lee 2000)
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) (Review) 10 Copyright 2008 TheCochrane Collaboration. Published by JohnWiley & Sons, Ltd.
-
8/13/2019 Kefpod o Final Pres
19/43
There is decreased susceptibility to drugs
(Chloramphenicol, Ampicillin, Chloramphenicol,
Cotrimoxazole & Ciprofloxacin) with consequent
therapeutic failure
To complicate further, it is often necessary to commence
treatment before the results of diagnosis or laboratory
sensitivity tests for resistance are available
Threlfall EJ. EID 2008;14[5]:860-
-
8/13/2019 Kefpod o Final Pres
20/43
Incidence of multi-drug resistant [MDR]
salmonella typhi is as high as 92%
Krishnan P. IJPM 2009;52[4]:505-8
Similarly ciprofloxacin resistant enteric fever
has evolved due to their rampant use Capoor MR. JMM 2007;56:1490-4
-
8/13/2019 Kefpod o Final Pres
21/43
Ciprofloxacin resistant Typhoid isolates
..rising incidence in Developed countries
Incidence of resistance to ciprofloxacin in isolates of S. typhi [UK, 2006]
%
Threlfall EJ. EID 2008;14[5]:860-1
Major concern..Antibacterial Resistance
-
8/13/2019 Kefpod o Final Pres
22/43
Ciprofloxacin resistant Typhoid isolates
rising incidence confirmed in India
Characterized by rising MIC levels [>0.25 mcg/ml]
MIC
[mcg/ml]>
S t hi i t t Fl i l
-
8/13/2019 Kefpod o Final Pres
23/43
S. typhi resistance to Fluoroquinolones
in vitro Study, New Delhi
Indiscriminate use of the existing therapeutic options forenteric fever has resulted in growing incidence of resistance
31 ciprofloxacin resistant isolates were evaluated for
sensitivity to advanced Fluoroquinolones & Azithromycin
Most of these drugs showed raised MIC levels
Advanced fluoroquinolones including Gatifloxacin showedresistance
Capoor MR. JMM 2007;56:1490-4
-
8/13/2019 Kefpod o Final Pres
24/43
Rationale for combination in
Typhoid fever
-
8/13/2019 Kefpod o Final Pres
25/43
Why Combination ?
Due to the increasing incidence of resistance of the
pathogens causing typhoid to the currently used
therapies , there is a need of Using combination of
drugs
The advantage of combination of drugs
Added synergy of the two drugs
Faster cure
Increases success rate
Increased pt compliance
-
8/13/2019 Kefpod o Final Pres
26/43
-
8/13/2019 Kefpod o Final Pres
27/43
Ofloxacin + Cefpodoxime Rationale
Typhoid or Enteric fever is an endemic infection inIndia
Fluoroquinolones with their intracellular action and
longer half life offer quicker defervescence in suchcasesDrug of Choice
Inadequate or Rampant use of these drugs has
resulted in increased incidence of plasmid resistanceto DNA gyrase
Newer advanced fluoroquinolones too are resistant in
such cases
-
8/13/2019 Kefpod o Final Pres
28/43
Ofloxacin + Cefpodoxime Rationale
Second-line therapy including Ceftriaxone &
Cefotaxime require parenteral administration
Combination with Oral Cephalosporin offers
complementary site of action taking care of
resistant organisms when used in INITIALLINEsettings
Ofl i i T h id
-
8/13/2019 Kefpod o Final Pres
29/43
Ofloxacin in TyphoidClinical efficacy
Studies by Yousuf (1992), Parry(2007) have demonstrated efficacy of
Ofloxacin (200 mg or 10 mg/kg twice daily for 7 to 14 days)
in uncomplicated Typhoid
-
8/13/2019 Kefpod o Final Pres
30/43
-
8/13/2019 Kefpod o Final Pres
31/43
9 pts with typhoid fever were given ofloxacin in a
daily dosage of 400 mg for 10 days
All patients recovered with no relapses
No case of Salmonella typhi carriage was recorded.
According to our results, ofloxacin could beconsidered as one of the alternatives for treating
typhoid fever
J P Stahl etal. Pathologiebiologie (1986) Volume: 34, Issue: 5, Pages: 505-507
-
8/13/2019 Kefpod o Final Pres
32/43
3rdgeneration cephalosporin
Reaches therapeutic concentrations in
respiratory tract and genitourinary tracts and
bile (PI)
C f d i P til
-
8/13/2019 Kefpod o Final Pres
33/43
Cefpodoxime Proxetil
TyphoidClinical efficacy
A study from Asian population has reported about
86% efficacy for cefpodoxime in the treatment of
typhoid fever.
In Bangladesh, where typhoid fever is also
endemic, a clinical trial showed cefpodoxime to be
highly efficacious in the treatment of typhoid fever
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2008, p. 802803
-
8/13/2019 Kefpod o Final Pres
34/43
Kefpod O
Composition
Each tablet of Kefpod O contains
Cefpodoxime 200 mg + Ofloxacin 200 mg
Ofl i
-
8/13/2019 Kefpod o Final Pres
35/43
Ofloxacin
2nd generation fluroquinolone
BactericidalActs on DNA Gyrase and
topoisomerase IV
Broad Spectrum
S/E profile of ofloxacin is better than other
fluroquinolones
Ofl i
-
8/13/2019 Kefpod o Final Pres
36/43
Ofloxacin
Ofloxacin is widely distributed to body tissues
Between 65 % & 80% of an administered oral dose
of ofloxacin is excreted unchanged via the kidneys
within 48 hrs of dosing
Usual dose of ofloxacin : 200-400 mg BD for 5-7
days
Cefpodoxime Proxetil
-
8/13/2019 Kefpod o Final Pres
37/43
Cefpodoxime Proxetil
3rdGeneration cephalosporin
Bactericidalacts on the organisms by inhibiting
bacterial cell wall synthesis
Very active against gram positive and gram
negative organisms
Has excellent tissue penetration including bile and
good half life
The usual dosing is- 200 mg BD for 7-10 days
C f d i P il
-
8/13/2019 Kefpod o Final Pres
38/43
Cefpodoxime Proxetil
Expanded spectrum cephalosporins such asCefpodoxime Proxetil shows the promising
results in the management of typhoid
Cefpodoxime delivers the desired
characteristics of an antibiotic and may be the
treatment of choice for MDR typhoid fever
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2008, p. 802803
K f d O
-
8/13/2019 Kefpod o Final Pres
39/43
Kefpod O
Cefpodoxime Proxetil Ofloxacin Benefits
3rdgeneration
cephalosporin
2ndgeneration
Fluroquinolone
Complementary different
site of actions & thereforemore useful in tackling
resistanceInhibits cell wall synthesis Inhibits nuclear DNA
gyrase for replication
Broad spectrum including
gm-ve organisms
Broad spectrum involving
gmve
Ideal for Typhoid
Achieve therapeutic
concentration in bile
Achieve therapeutic
concentration in bile
Target cell concentration
achieved for immediate &
sustained efficacy to
prevent further resistance
200 mg BD 200 mg BD for Typhoid Complementary BD dosage
Compatible Pharmacokinetic
-
8/13/2019 Kefpod o Final Pres
40/43
Side Effects
Nausea, Vomiting, GI disturbances
Drug Interactions
Antacid, Theophylline, Warfarin
-
8/13/2019 Kefpod o Final Pres
41/43
Indication :
Typhoid fever
Dosage:
1 tablet to be taken twice daily after meals for 7-
14 days depending upon the severity of
infections
USP OF Combination of Cefpodoxime and
-
8/13/2019 Kefpod o Final Pres
42/43
USP OF Combination of Cefpodoxime and
Ofloxacin
Synergistic effects of the drugs
Faster cure
Better success rate
Less chances of relapse
Less chances of Carrier stage
Better patient compliancethe patient has to take only
one tablet as against 2 separately
USP OF Combination of Cefpodoxime and
-
8/13/2019 Kefpod o Final Pres
43/43
USP OF Combination of Cefpodoxime and
Ofloxacin
The combination would have good potential and
would be useful addition for the physician in the
treatment of typhoid including MDR Typhoid